NEW YORK (Reuters Health) – Although cumulative dose is important, how cisplatin is administered to young patients with cancer also
Continue reading »Home ยป
Breaking the ‘stalemate’ in the most common soft tissue sarcoma in children
A phase 2 clinical trial has found that combining a molecular targeted drug called temsirolimus with chemotherapy shows promise in
Continue reading »